All lobbying filings

FERRING PHARMACEUTICALS, INC.

FERRING PHARMACEUTICALS, INC. filed a Q3 report for FERRING PHARMACEUTICALS, INC. on October 16, 2025.

Lobbying for FERRING PHARMACEUTICALS, INC.

All filings by FERRING PHARMACEUTICALS, INC. · Everything FERRING PHARMACEUTICALS, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 16, 2025

Expenses

$160,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to fertility treatment and coverage (no bill); issues related to federal employee health care coverage (Family Building FEHB Fairness Act, H.R. 1670 / S. 797), issues related to veterans health coverage (Veterans Infertility Treatment Act, H.R. 220 / no Senate bill), issues related to infertility coverage for members of the military included in the National Defense Authorization Act (S. 2296, Sec. 705 / H.R. 3838, Sec. 703).

Taxation/Internal Revenue Code

Issues related to establishing a tax credit for fertility treatments (IVF Access and Affordability Act, H.R. 1878 / no Senate bill; Infertility Treatment Affordability Act, H.R.4639 / no Senate bill).

Bills named in this filing 7

H.R. 1670
Family Building FEHB Fairness Act
S. 797
Family Building FEHB Fairness Act
H.R. 220
Veterans Infertility Treatment Act of 2025
S. 2296
National Defense Authorization Act for Fiscal Year 2026
H.R. 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
H.R. 1878
IVF Access and Affordability Act
H.R. 4639
Infertility Treatment Affordability Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.